A lawsuit was filed on behalf of investors in Osiris Therapeutics, Inc. (NASDAQ:OSIR) shares over alleged securities laws violations and NASDAQ:OSIR investors should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 01/04/2016 --A shareholder of Osiris Therapeutics, Inc. filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Securities Laws by Osiris Therapeutics, Inc. in connection with certain allegedly false and misleading statements.

Investors who purchased shares of Osiris Therapeutics, Inc. (NASDAQ:OSIR) have certain options and for certain investors are short and strict deadlines running. Deadline: January 22, 2016. NASDAQ:OSIR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint the plaintiff alleges on behalf of purchasers of Osiris Therapeutics, Inc. (NASDAQ:OSIR) common shares between May 12, 2014 and November 20, 2015, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between May 12, 2014 and November 20, 2015 defendants issued false and misleading statements to investors and/or failed to disclose that Osiris Therapeutics, Inc. improperly recognized revenue under contracts it had with its distributors, that Osiris Therapeutics, Inc's disclosure controls and procedures were not effective as of December 31, 2014, March 31, 2015, and June 30, 2015, and that as a result, defendants' statements about Osiris Therapeutics' business and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On November 16, 2015, Osiris Therapeutics, Inc. (NASDAQ:OSIR) filed its 10-Q Quarterly Report, disclosing multiple restatements in prior financial results, including three restatements made related to distributor relationships. As a result of these adjustments, Osiris Therapeutics, Inc. (NASDAQ:OSIR) missed revenue targets in three of the last four quarters. Shares of Osiris Therapeutics, Inc. (NASDAQ:OSIR) declined to as low as $9.80 per share on November 17, 2015.

On December 31, 2015, NASDAQ:OSIR shares closed at $10.38 per share.

Those who purchased shares of Osiris Therapeutics, Inc. (NASDAQ:OSIR) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com